Simon Pimstone

Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^

British Columbia Clinical Research Infrastructure Network used to provide clinical research services. The company was headquartered in Canada.

Cyon Therapuetics, Inc. operates as a clinical phase biotechnology company. It provides anti-PCSK9 which develops the treatment for sepsis-severe. The company was founded by James Russell, Keith Walley and John Boyd in May 2014 and is headquartered in Vancouver, Canada.

Topirx Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Bartlett, IL.

Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada.

Providence Health Care Research Institute operates as an integrated healthcare research enterprise. Its priorities heart and lung, healthy aging, HIV/AIDS, kidney risks and illnesses, mental health, and urban health and addiction. The company was founded in 2005 and is headquartered in Vancouver, Canada.